AAS ›› 2015, Vol. 46 ›› Issue (1): 81-84.doi: 10.16098/j.issn.0529-1356.2015.01.014

Previous Articles     Next Articles

Anti-tumor effect and mechanism of cyclooxygenase 2 inhibitor in pancreatic cancer

GU Zhuo-yu 1,2 LI Jun 1,2* LI Si-yuan 2* XIAO Zhi-wei2 ZHOU Ting3   

  1. 1. Department of Endocrinology and Metabolism, the First Affiliated Hospital; 2.Key Laboratory of Ministry of Education, Xinjiang Endemic and Ethnic Diseases; 3. the Central Laboratory, the First Affiliated Hospital, 
    Shihezi University School of Medicine, Xinjiang Shihezi 832002, China
  • Received:2014-09-01 Revised:2014-10-13 Online:2015-02-06 Published:2015-02-06
  • Contact: LI Jun , LI Si-yuan E-mail:846030498@qq.com

Abstract:

Objective To investigate the effect of COX-2 inhibitor on proliferation, migration, invasion and the expression of COX-2, matrix metalloproteinase (MMP)-14 in pancreatic cancer cell and its possible anti-tumor mechanism. Methods Human pancreatic cancer cell line PANC-1 was treated with diverse concentrations of COX-2 inhibitor celebrex (20, 60, 100μmol/L). Cell proliferation, invasion and migration capabilities were measured by MTT colorimetry, Transwell invasion assay, and scratch assay. The protein expression of COX-2 and MMP-14 was assessed by ELISA. Results The proliferation, invasion and migration capabilities were decreased in a concentration-dependent manner by COX-2 inhibitor (P<0.05). The protein expression of COX-2 and MMP-14 was correspondingly reduced (P<0.05). MMP-14 expression was positively correlated with COX-2 expression (r=0.873,P<0.01). Conclusion COX-2 inhibitor may down-regulate MMP-14 expression via inhibiting COX-2 expression, then attenuating the proliferation, invasion and migration of human pancreatic cancer cell in a concentration-dependent manner, contributing to its anti-tumor effect in pancreatic cancer.

Key words: Pancreatic cancer, Cyclooxygenase 2 inhibitor, Matrix metalloproteinase 14, Invasion, Migration, Methyl thiazolyl tetrazolium method, Human